Activation of glycogen synthase kinase 3 induces Alzheimer-like hyperphosphorylation of cytoskeleton protein and cell damage

Progress in Biochemistry and Biophysics

Volumn 31, Issue 6, 2004, Pages 532-537

  Yu, Jing ^a   Deng, Yan Qiu ^a   Yang, Ying ^a   Zhang, Jia Yu ^a   Zhang, Ye Ping ^a   Zhang, Shao Hua ^a   Wang, Jian Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer disease; Glycogen synthase kinase 3; Neurofilament; Phosphorylation; Wortmannin

Indexed keywords

CYTOSKELETON PROTEIN; GLYCOGEN SYNTHASE KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TAU PROTEIN; WORTMANNIN;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL METABOLISM; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; MOUSE; NEUROBLASTOMA CELL; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NONHUMAN; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALIA;

EID: 3242785633     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wang J, Tung Y C, Wang Y, et al. Hyperphosphorylation and accumulation of NF proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett, 2001, 507 (1): 81-87
2. Nixon R A. The slow axonal transport of cytoskeletal proteins. Curr Opin Cell Biol, 1998, 10 (1): 87-92
3. Wang J Z, Wu Q, Smith A, et al. Tau is phosphoiylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett, 1998, 436 (1): 28-34
4. Pei J J, Braak E, Braak H, et al. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol, 1999, 58 (9): 1010-1019
5. Phiel C J, Wilson C A, Lee V M Y, et al. GSK-3a regulates production of Alzheimer's disease amyloid-β Peptides. Nature, 2003, 423 (6938): 435-439
6. Lucas J J, Hernandez F, Gomez-Ramos P, et al. Decreased nuclear-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3 conditional transgenic mice. EMBO J , 2001, 20 (1-2): 27-39
7. Spittaels K, Van den Haute C, Van Dorpe J, et al. Glycogen synthase kinase-3 phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem, 2000, 275 (52): 41340-41349
8. Liu S J, Zhang A H, Li H L, et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem, 2003, 87 (6): 1333-1344
9. Srivastava A K, Pandey S K. Potential mechanism (s) involved in the regulation of glycogen synthesis by insulin. Mol Cell Biochem, 1998. 182 (1-2): 135-141
10. Cross D A, Alessi D R, Cohen P, et al. Inhibition of GSK-3 by insulin mediated by PKB. Nature, 1995, 378 (6559): 785-789
11. Delcommenne M, Tan C, Gray V, et al. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/ AKT by the integrin-linked kinase. Proc Natl Acad Sci USA, 1998, 95 (19): 11211-11216
12. Chan T O, Rittenhouse S E, Tsichlis P N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Ann Rev Biochem, 1999, 68: 965-1014
13. Tsujio I, Tanaka T, Kudo T, et al. Inactivation of glycogen synthase kinase-3 by protein kinase C delta: implications for regulation of tau phosphorylation. FEBS Lett, 2000, 469 (1): 111-117
14. Wang Q M, Fiol C J, Anna A, et al. GSK-3beta; is a dual specificity kinase differentially regulated by Tyrosine and Serine/Threonine phosphorylation. J Biol Chem, 1994, 269 (20): 14566-14574
15. Singh TJ, Haque N, Grundke-Iqbal I, et al. Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3. FEBS Letters, 1995, 358 (3): 267-272
16. Lovestone S, Hartley C L, Pearce J, et al. Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience, 1996, 3 (4): 1145-1157
17. Sperber B R, Leight S, Goedert M, et al. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci Lett, 1995, 197 (2): 149-153
18. Zheng-Fischhofer Q, Biernat J, Mandelkow E M, et al. Sequential phosphorylation of Tau by glycogen synthase kinase-3 beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem, 1998, 252 (3): 542-552
19. Flaherty D B, Soria J P, Tomasiewicz H G, et al. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants. J Neurosci Res, 2000, 62 (3): 463-472
20. Bhat R V, Budd S L. GSK3beta signalling: casting a wide net in Alzheimer's disease. Neurosignals, 2002, 11 (5): 251-261
21. Wang J Z, Wang Q, Wu Q L, et al. Prog Biochem Biophys, 1999, 26 (4): 373-402
22. Baum L, Seger R, Woodgett J R, et al. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement. Brain Res Mol Brain Res, 1995, 34 (1): 1-17
23. Merrick S E, Trojanowski J Q, Lee V M. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J Neurosci, 1997, 17 (15): 5726-5737
24. Nixon R A. The regulation of neurofilament protein dynamics by phosphorylation: clues to neurofibrillary pathobiology. Brain Pathol, 1993, 3 (1): 29-38
25. Schlaepfer W W, Micko S. Characterization of the calcium-induced disruption of neurofilaments in rat peripheral nerve. Brain Res, 1979, 168 (2): 299-309
26. Masaki R, Saito T, Yamada K, et al. Accumulation of phosphorylated neurofilaments and increase in apoptosis-specific protein and phosphorylated c-Jun induced by proteasome inhibitors. J Neurosci Res, 2000, 62 (1): 75-83
27. Ekinci F J, Linsley M D, Shea T B. β-Amyloid-induced calcium influx induces apoptosis in culture by oxidative stress rather than tau phosphorylation. Molecular Brain Research, 2000, 76 (2): 389-395
28. Li S P, Deng Y Q, Wang Y P, et al. Melatonin protects SHSY5Y neuroblastoma cells from calyculin A-induces neurofilament impairment and neurotoxicity. J Pineal Res, 2004, 36 (3): 186-191
29. Marx J. New leads on the "How" of Alzheimer's. Science, 2001, 293 (5538): 2192-2194